台股 » 個股 » 佳醫 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

佳醫

(4104)
可現股當沖
  • 股價
    91.8
  • 漲跌
    ▼0.1
  • 漲幅
    -0.11%
  • 成交量
    148
  • 產業
    上市 生技醫療類股
  • 331人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
佳醫 (4104)籌碼相關-聯邦-大業 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

聯邦-大業 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/0200.00092.5092.8002880.00%
2024/04/26091.6000.0091.6002840.00%
2024/04/1100.00194.6095.00-1237-0.42%
2024/04/08197.5000.0097.1012240.45%
2024/03/2800.000.296.5596.40-0.2214-0.10%
2023/07/260.291.9000.0091.500.27190.03%
2023/07/2100.00193.6093.90-1711-0.14%
2023/07/1900.000.298.2095.40-0.2700-0.03%
2023/07/1800.00196.4095.60-1693-0.14%
2023/07/17198.3000.0098.5016890.15%
2023/07/14196.0000.0095.6016860.15%
2023/07/1300.00095.4094.6006870.00%
2023/06/150.292.0000.0091.700.25630.04%
2023/05/0400.000.196.0095.70-0.1589-0.01%
2023/04/1300.000.184.4086.20-0.1496-0.01%
2023/04/07180.3000.0081.6014990.20%
2023/03/290.179.7000.0079.100.14810.01%
2023/03/1600.000.178.5078.00-0.1460-0.01%
2023/02/130.174.6000.0075.400.13540.01%
2022/10/2100.000.260.9060.50-0.2228-0.09%
2022/09/2000.00366.7066.60-3234-1.28%
2022/09/1900.00166.8066.70-1238-0.42%
2022/08/3000.00166.8067.20-1239-0.42%
2022/08/29468.4000.0068.5042321.72%
2022/07/01166.4000.0066.3013940.25%
2021/05/1200.00156.0056.90-1306-0.33%
2021/05/0400.001.457.7757.90-1.4278-0.49%
2020/12/14156.7000.0056.6011950.51%
2020/11/2500.00157.1057.00-1214-0.47%
2020/10/30156.3000.0056.2012680.37%
2020/06/2200.001058.8858.70-10495-2.02%
2020/06/151058.4600.0058.00104742.11%
2020/05/2700.001256.8156.60-12442-2.71%
2020/03/1600.00550.7050.60-5282-1.77%
2020/02/26652.9000.0053.1062532.37%
2020/02/25352.8000.0052.8032561.17%
2020/02/24353.1000.0052.9032581.16%
2019/12/23153.8000.0053.8012330.43%
2019/10/21153.0000.0053.0013110.32%
2019/06/27551.5000.0051.5051742.87%
2019/06/1300.00150.4050.40-1185-0.54%
2019/05/29150.7000.0050.8011730.58%
2019/01/1400.00147.2047.70-1134-0.74%
2019/01/11147.3000.0047.1511290.77%
2019/01/1000.00247.0547.15-2128-1.56%
2019/01/04246.9300.0046.7021291.54%
2018/04/1000.00149.0548.90-1445-0.22%
2018/03/29148.4500.0048.3513270.31%
佳醫整併血液透析通路效益顯 下半年營運拚成長Anue鉅亨-2022/09/28
〈佳醫法說〉東南亞市場將調整產品結構 2-3年後可望發酵Anue鉅亨-2020/09/24
佳醫 相關文章
佳醫 相關影音